Showing results (1061-1070 of 5,692) with videos related to
Sort By:
Pageof 570
The Oncologist|March 28, 2019
Clinical and Prognostic Characteristics of 53 Cases of Extracranial Malignant Rhabdoid Tumor in Children. A Single-Institute Experience from 2007 to 2017Haiyan Cheng, Shen Yang, Siyu Cai, et al.The Oncologist|February 28, 2021
Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on FulvestrantGary Schwartz, Kevin Shee, Bianca Romo, et al.The Oncologist|March 17, 2021
UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan-Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall SurvivalAnkan Bandyopadhyay, Siddharth Sharma, Digambar Behera, et al.The Oncologist|March 22, 2021
Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in MelanomaAleksei Viktorovich Novik, Svetlana Anatolievna Protsenko, Irina Alexandrovna Baldueva, et al.The Oncologist|January 25, 2014
Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imagingBrett Hughes, Linda Mileshkin, Peter Townley, et al.The Oncologist|October 23, 2012
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Sarah Barton, Eliza A Hawkes, Andrew Wotherspoon, et al.The Oncologist|June 28, 2014
Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesMaria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, et al.The Oncologist|May 30, 2014
Current status of gene expression profiling to assist decision making in stage II colon cancerCheng E Chee, Neal J MeropolThe Oncologist|June 15, 2014
The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for human useHector Boix-Perales, Jeanett Borregaard, Kristina Bech Jensen, et al.The Oncologist|June 6, 2014
Seizure prognosis in brain tumors: new insights and evidence-based managementCharles J Vecht, Melissa Kerkhof, Alberto Duran-PenaPageof 570